Literature DB >> 30015851

miR‑199a‑3p/Sp1/LDHA axis controls aerobic glycolysis in testicular tumor cells.

Shihua Zhou1, Ziqian Min1, Kang Sun1, Sijie Qu1, Jinrun Zhou1, Hongyan Duan1, Huawei Liu1, Xiaowen Liu1, Zhijun Gong2, Dan Li1.   

Abstract

Aerobic glycolysis is one of the characteristics of tumor metabolism and contributes to the development of tumors. Studies have identified that microRNA (miRNA/miR) serves an important role in glucose metabolism of tumors. miR‑199a‑3p is a member of the miR‑199a family that controls the outcomes of cell survival and death processes, and previous studies have indicated that the expression of miR‑199a‑3p is low and may be an inhibitor in several cancer types, including testicular tumors. The present study discussed the role and underlying mechanism of miR‑199a‑3p in aerobic glycolysis of Ntera‑2 cells and identified its downstream factors. Firstly, miR‑199a‑3p exhibited an inhibitory effect on lactic acid production, glucose intake, and reactive oxygen species (ROS) and adenosine 5'‑triphosphate (ATP) levels in Ntera‑2 cells. Then, using bioinformatics, recombinant construction and a dual luciferase reporter gene system, transcription factor Specificity protein 1 (Sp1) was determined as the direct target of miR‑199a‑3p. Also, downregulation of Sp1 by RNA interference decreased lactic acid production, glucose intake, and ROS and ATP levels in Ntera‑2 cells. Subsequently, through a functional rescue experiment, it was identified that the overexpression of Sp1 may abate the inhibition of miR‑199a‑3p on glucose metabolism, with the exception of ATP level, suggesting a reciprocal association between Sp1 and miR‑199a‑3p. Finally, it was determined that miR‑199a‑3p overexpression and Sp1 knockdown decreased lactate dehydrogenase A (LDHA) protein expression, which indicated that LDHA is a downstream target of the miR‑199a‑3p/Sp1 signaling pathway. To additionally verify the regulation of LDHA expression by 199a‑3p/Sp1, a LDHA promoter reporter plasmid was generated and the high activity of the promoter, which contained 3 potential Sp1 binding elements, was confirmed. In addition, the overexpression of Sp1 led to the increased activity of the LDHA promoter, whereas knockdown of Sp1 exhibited the opposite effect. Therefore, the results of the present study demonstrated that miR‑199a‑3p can inhibit LDHA expression by downregulating Sp1, and provided mechanistic evidence supporting the existence of a novel miR‑199a‑3p/Sp1/LDHA axis and its critical contribution to aerobic glycolysis in testicular cancer cells.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30015851     DOI: 10.3892/ijmm.2018.3771

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  5 in total

1.  Prevention of acute graft-vs.-host disease by targeting glycolysis and mTOR pathways in activated T cells.

Authors:  Rui-Qing Zhou; Xiaobo Wang; Yong-Bin Ye; Bo Lu; Jing Wang; Zi-Wen Guo; Wen-Jian Mo; Zheng Yang; Pathomthat Srisuk; Le-Ping Yan; Xiao-Jun Xu
Journal:  Exp Ther Med       Date:  2022-05-16       Impact factor: 2.751

Review 2.  Crosstalk between noncoding RNAs and ferroptosis: new dawn for overcoming cancer progression.

Authors:  Lei Zhang; Xiulan Zheng; Wen Cheng; Xuefei Zhang; Lingling Wang; Haixia Li
Journal:  Cell Death Dis       Date:  2020-07-24       Impact factor: 8.469

Review 3.  Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy.

Authors:  Yangbo Feng; Yanlu Xiong; Tianyun Qiao; Xiaofei Li; Lintao Jia; Yong Han
Journal:  Cancer Med       Date:  2018-11-06       Impact factor: 4.452

Review 4.  Revisiting cancer hallmarks: insights from the interplay between oxidative stress and non-coding RNAs.

Authors:  Li Zhou; Zhe Zhang; Zhao Huang; Edouard Nice; Bingwen Zou; Canhua Huang
Journal:  Mol Biomed       Date:  2020-08-31

5.  MYC Promotes LDHA Expression through MicroRNA-122-5p to Potentiate Glycolysis in Hepatocellular Carcinoma.

Authors:  Xiaofei Wang; Penghua Zhang; Ke Deng
Journal:  Anal Cell Pathol (Amst)       Date:  2022-08-18       Impact factor: 4.133

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.